Eliquis (generic name apixaban) is a blood thinning drug developed by New York City-based Bristol-Meyers Squibb and Pfizer. Eliquis is administered to reduce the risk of blood clots for patients with Atrial fibrillation (AFib) and Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), as well as people recovering from Hip or Knee Replacement Surgeries. Its manufacturers are trying to expand on its list of approved uses.

Eliquis is one of three new drugs (the others being Pradaxa and Xarelto) seeking to gain a portion of the potential $10 billion market for this new brand of pharmaceuticals. The prevailing treatment for decades has been warfarin (marketed under the name Coumadin); Eliquis offers patients less intensive monitoring than Coumadin as one of its signal benefits. Unlike Coumadin, however, which has been generic for years and costs about $200 per year, Eliquis, Xarelto and Pradaxa can cost consumers (as well as the U.S. government and insurance companies) many thousands of dollars per patient in annual costs. Additionally, there is no commercial reversal agent available, which may lead to more serious and possibly harder to treat side effects than with Coumadin.

Eliquis Lawsuits

Eliquis has recently been linked to internal bleeding and other serious side effects. These serious internal bleeding events can be extremely difficult to treat. Warning signs and symptoms of serious internal bleeding may include:

  • Discolored urine (blood in the urine)
  • Red or black colored stool
  • Vomiting or coughing up blood
  • Frequent nose bleeds or gum bleeding
  • Weakness and sweeling in the extremities
  • Any other unusual bleeding

Eliquis is said to present less of a risk of bleeding in the brain than warfarin when given to AFib patients. The trouble is that, as with Pradaxa and Xarelto, Eliquis may cause more serious bleeding events in other regions of the body. In turn, these bleeding events may be more difficult to treat. With Coumadin, which thins the blood by blocking Vitamin K, administering a bleeding patient Vitamin K can serve as an antidote to a severe bleeding event. There is no such antidote to date for Eliquis, which in turn can lead to more severe outcomes for those suffering from anticoagulant-induced bleeding events.

Do I have an Eliquis Lawsuit?

The Eliquis Attorneys of Slater Slater Schulman LLP are investigating the causes of alleged Eliquis induced bleeding incidents. If you or someone you love has suffered an Eliquis severe internal bleeding event, you may have an Eliquis lawsuit and should contact an Eliquis lawyer at Slater Slater Schulman LLP for a free consultation by filling out the form on this page or by calling us at (800) 251-6990. There is no financial obligation on your part for this free consultation.

Medical disclaimer: Please note that any change in medications should be made only after consulting with your doctor about the risks and benefits of doing so, and should not be based on any information contained in this web site.